Pliant Therapeutics News

Latest Pliant Therapeutics Stock News & PLRX Headlines

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results

2 days ago | globenewswire.com

Pliant Therapeutics Announces Presentation of PLN-101095 Preclinical and Clinical Data at the 2026 Annual Meeting of the Society for Immunotherapy of Cancer

6 days ago | globenewswire.com

Pliant Therapeutics Announces Presentations at the 2026 Annual Meeting of the Society for Immunotherapy of Cancer

16 days ago | globenewswire.com

Pliant Therapeutics Appoints Craig Blanchette, Ph.D., as Senior Vice President, Research (siRNA)

a month ago | globenewswire.com

Pliant Therapeutics Announces Upcoming Presentation at European Society for Medical Oncology Congress 2026

a month ago | globenewswire.com

Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer

a month ago | globenewswire.com

Reviewing Pliant Therapeutics (NASDAQ:PLRX) & Black Diamond Therapeutics (NASDAQ:BDTX)

2 months ago | defenseworld.net

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results

3 months ago | globenewswire.com

Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D.

4 months ago | globenewswire.com

Pliant Therapeutics, Inc. (PLRX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

6 months ago | seekingalpha.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

PLRX

Pliant Therapeutics

$ 0.6970

-5.81%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated a day ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Pliant Therapeutics News

Latest Pliant Therapeutics Stock News & PLRX Headlines

Download App

People Also Watch

Explore our Tools